| Vaccination of chimpanzees against infection by the hepatitis C virus. QL Choo, G Kuo, R Ralston, A Weiner, D Chien, G Van Nest, J Han, ... Proceedings of the National Academy of Sciences 91 (4), 1294-1298, 1994 | 760 | 1994 |
| Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. MJ Koziel, D Dudley, JT Wong, J Dienstag, M Houghton, R Ralston, ... Journal of immunology (Baltimore, Md.: 1950) 149 (10), 3339-3344, 1992 | 577 | 1992 |
| Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts CE Greer, CM Wheeler, MB Ladner, K Beutner, MY Coyne, H Liang, ... Journal of clinical microbiology 33 (8), 2058-2063, 1995 | 408 | 1995 |
| Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients S Susser, C Welsch, Y Wang, M Zettler, FS Domingues, U Karey, ... Hepatology 50 (6), 1709-1718, 2009 | 395 | 2009 |
| Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV MJ Koziel, D Dudley, N Afdhal, QL Choo, M Houghton, R Ralston, ... Journal of virology 67 (12), 7522-7532, 1993 | 392 | 1993 |
| Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses R Ralston, K Thudium, K Berger, C Kuo, B Gervase, J Hall, M Selby, ... Journal of virology 67 (11), 6753-6761, 1993 | 294 | 1993 |
| The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor. R Ralston, JM Bishop Proceedings of the National Academy of Sciences 82 (23), 7845-7849, 1985 | 265 | 1985 |
| Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53 ED Harlow, NM Williamson, R Ralston, DM Helfman, TE Adams Molecular and cellular biology 5 (7), 1601-1610, 1985 | 253 | 1985 |
| Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. CL Addison, T Braciak, R Ralston, WJ Muller, J Gauldie, FL Graham Proceedings of the National Academy of Sciences 92 (18), 8522-8526, 1995 | 244 | 1995 |
| The protein products of the myc and myb oncogenes and adenovirus E1a are structurally related R Ralston, JM Bishop Nature 306 (5945), 803-806, 1983 | 213 | 1983 |
| Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. AL Erickson, M Houghton, QL Choo, AJ Weiner, R Ralston, E Muchmore, ... Journal of immunology (Baltimore, Md.: 1950) 151 (8), 4189-4199, 1993 | 199 | 1993 |
| Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells RR Spaete, ME Rugroden, QL Choo, K Berger, K Crawford, C Kuo, ... Virology 188 (2), 819-830, 1992 | 177 | 1992 |
| Characterization of resistance mutations against HCV ketoamide protease inhibitors X Tong, S Bogen, R Chase, V Girijavallabhan, Z Guo, FG Njoroge, ... Antiviral research 77 (3), 177-185, 2008 | 158 | 2008 |
| Human ADAM33 messenger RNA expression profile and post-transcriptional regulation SP Umland, CG Garlisi, H Shah, Y Wan, J Zou, KE Devito, WM Huang, ... American journal of respiratory cell and molecular biology 29 (5), 571-582, 2003 | 128 | 2003 |
| Postentry neutralization of adenovirus type 5 by an antihexon antibody R Varghese, Y Mikyas, PL Stewart, R Ralston Journal of virology 78 (22), 12320-12332, 2004 | 124 | 2004 |
| Persistence of HCV despite antibodies to both putative envelope glycoproteins DY Chien, QL Choo, R Ralston, R Spaete, M Tong, M Houghton, G Kuo The Lancet 342 (8876), 933, 1993 | 122 | 1993 |
| Subcellular location of an abundant substrate (p36) for tyrosine-specific protein kinases S Courtneidge, R Ralston, K Alitalo, JM Bishop Molecular and cellular biology, 1983 | 117 | 1983 |
| Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120 RA Ogert, L Wojcik, C Buontempo, L Ba, P Buontempo, R Ralston, ... Virology 373 (2), 387-399, 2008 | 116 | 2008 |
| Discovery of narlaprevir (SCH 900518): a potent, second generation HCV NS3 serine protease inhibitor A Arasappan, F Bennett, SL Bogen, S Venkatraman, M Blackman, ... ACS medicinal chemistry letters 1 (2), 64-69, 2010 | 103 | 2010 |
| Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model V Tsai, DE Johnson, A Rahman, SF Wen, D LaFace, J Philopena, J Nery, ... Clinical cancer research 10 (21), 7199-7206, 2004 | 101 | 2004 |
Michael HoughtonVerified email at ualberta.ca